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Background: Brown adipose tissue (BAT) was considered essentially nonexistent in adults until
recent evidence obtained using 18-fluorodeoxyglucose (18-FDG) positron emission tomography/
computed tomography. It seems to play a role in whole body metabolism, but it has not been
evaluated in underweight conditions, such as in young females with constitutional leanness (CL)
or anorexia nervosa (AN).
Subjects and Methods: Thirty-eight subjects were evaluated from October 2011 to March 2012 :
7 CL (21.7  3.6 y, body mass index [BMI] 16.2  1.0 kg/m2), 7 AN (23.4  4.5 y, BMI 15.5  0.8), 3
of the 7 AN after stable refeeding (R-AN, 21.3  1.5 y, BMI 18.8  1.1), and 24 normal weight (NW)
women (25.6  3.9 y, BMI 22.2  1.5). Fasting resting metabolic rate and respiratory quotient were
measured by indirect calorimetry, body composition by bioimpedentiometry (only in CL, AN, and
refed AN), and BAT activity by 18-FDG positron emission tomography/computed tomography scan,
all in standardized conditions.
Results: All CL (100%), none of the AN and refed AN (0%), and 3 of the 24 NW (12%) subjects
showed FDG uptake. Average FDG maximum standardized uptake value was 11.4  6.7 g/mL in CL
and 5.5  1.2 g/mL (min 3.7, max 8.3) in the 3 NW subjects. In CL, the maximum standardized uptake
value was directly correlated to resting metabolic rate, corrected for fat-free mass, and inversely
correlated with respiratory quotient.
Conclusion: BAT activity has been shown in CL in resting thermoneutral conditions and may exert
a role against adipose tissue deposition. (J Clin Endocrinol Metab 98: 0000–0000, 2013)
Constitutional leanness (CL) represents a peculiar phys-iological condition whereby the body is resistant to
fat storage, even in overfeeding conditions. Therefore, it
may be a useful model for studying biological factors reg-
ulating energy balance, in particular energy expenditure.
This topic currently is of great interest, given the epidemic
of obesity, overall reduced physical exercise/exposure to
cold, and continuous search for antiobesity drugs able to
affect energy balance or expenditure, and so forth. To the
best of our knowledge, only a few studies have been car-
ried out on energy regulation in CL. In a previous study
(1), we evaluated resting metabolic rate (RMR), nonex-
ercise activity thermogenesis (NEAT), and respiratory
quotient (RQ), as index of preferential substrate oxida-
tion, in CL, anorexia nervosa (AN), and obesity. NEAT is
a facultative or regulatory component of adaptive ther-
mogenesis with a specific role in energy balance regulation
(ie, the prevention of long-term fat accumulation) (2); it is
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part of adaptive thermogenesis and is supposedly controlled
by the autonomic nervous system, with sympathetic activity
playing a stimulatory role. NEAT includes all minor activi-
tiesother thanvolitionalphysicalactivity, includingrepeated
musclecontractions (or fidgeting).TheroleofNEATinover-
all energy balance is becoming significant because of the in-
creasing lack of physical activity in affluent societies. In this
study (1), we reported significant increased NEAT in CL but
not in the other groups studied: AN and obese patients and
control normal weight (NW) subjects. In the CL group, RQ
also showed a negative correlation with NEAT (evaluated as
fidgeting), suggesting a potential correlation between NEAT
and fat oxidation.
In recent years, the combination of 18-fluorodeoxyg-
lucose (18F-FDG) positron emission tomography (PET)
with computed tomography (CT) has given clear evidence
of brown adipose tissue (BAT) activity in adult humans,
and several specific metabolic roles have been identified
(3–10). A well-documented action of BAT in regulatory
(cold or diet-induced, etc.) thermogenesis is also present.
Furthermore, BAT activity is regulated by the autonomic
nervous system and, among other things, requires free
fatty acids and glucose, which recently appeared to per-
haps play a role as mitochondrial fuel (8–11).
In this study, we aimed to detect BAT activity in different
groups of women (CL, AN, NW) and possibly correlate its
activity with the values obtained for RMR, NEAT, and RQ.
Subjects and Methods
The study group consisted of 38 young women, evaluated between
October 2011 and March 2012: 7 CL (21.7  3.6 y; body mass
index [BMI] 16.2  1.0 kg/m2); 7 restricted AN patients (AN:
23.44.5y,BMI15.50.8kg/m2),3ofwhomwerestudiedagain
after stable refeeding (R-AN: 21.3  1.5 y; BMI 18.8  1.1 kg/m2);
and 24 NW women who acted as controls (NW: 25.6  3.9 y; BMI
22.2  1.5 kg/m2). CL and AN patients were recruited in the out-
patient clinic for malnutrition secondary to eating disorders of the
Clinical Nutrition Unit of the Federico II University Hospital. Age-
matchedcontrol subjectswereselectedamongfemalepatients in the
BMI range of 20 to 25 kg/m2, who underwent total body 18F-FDG
PET/CT for routine ordinary follow-up: none of them were smok-
ers, all had stable body weight and were free of neoplastic (or other)
diseases for at least 1 year.
Diagnosis of AN was made according to Diagnostic and Sta-
tistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
criteria. CL definition was supported by the presence of menses,
normal thyroid and cardiac function, normal insulin-resistance,
and so forth (for additional details see Ref. 1). AN patients and
CL women were free from any endocrine, metabolic, or other
relevant diseases. Three of the 7 AN patients had completed the
refeeding therapeutic protocol and were studied after at least 2
months of stable regain of 10% initial body weight.
All PET/CT studies were performed between October and
March to minimize seasonal influences on BAT activity. Air tem-
perature was controlled in both waiting and injection rooms, as
well as in the scan room, and kept constant at 20° to 22°C and
22° and 24°C, respectively. All subjects stayed in the waiting
room 15 minutes before tracer administration. The 18F-FDG
PET/CT scans were acquired after 8 hours fasting and 60 to 90
minutes after intravenous administration of 18F-FDG (350–370
MBq). None of the patients reported uneasiness or cold percep-
tion or shivering throughout the procedure. Blood glucose level,
measured just before tracer administration, was 120 mg/dL in
all patients. The 18F-FDG PET/CT scans were obtained using a
combined PET/CT Discovery LS8 (GE Medical Systems). All
scans were performed in two-dimensional mode. Emission scan
was carried out in the caudo-cranial direction, from the upper
thigh to the base of the skull (4 min/each bed position). Iterative
image reconstruction was completed with an ordered subset-
expectation maximization algorithm (2 iterations, 28 subsets). A
CT with a 4-slice multidetector helical scanner was used (detec-
tor row configuration 4  5 mm, pitch 1.5, gantry rotation speed
of 0.8 seconds per revolution, table speed of 30 mm per gantry
rotation, 140 kV and 80 mA). Attenuation-corrected emission
data were obtained using filtered back projection CT recon-
structed images (Gaussian filter with 8 mm full width at half
maximum) to match PET resolution. Transaxial, sagittal, and
coronal images and coregistered images were examined using
Xeleris software (GE Healthcare).
All images were reviewed at a workstation using PET/CT
fusion software (Volumetrix for PET; GE Healthcare). Each set
of PET/CT studies was interpreted by two experienced (LP and
RF) operators by consensus. The value of 18F-FDG uptake in
BAT was considered present when the uptake in the character-
istic areas of brown fat localization, having the CT density of
adipose tissue (250 to 50 Hounsfield units), was greater than
background soft-tissue activity. Otherwise, 18F-FDG BAT was
considered absent. In addition, when 18F-FDG BAT uptake was
present, the site of uptake was determined as: 1) neck and su-
praclavicular, 2) mediastinum and paravertebral, 3) prevertebral
and intercostals, 4) paracardiac, or 5) infradiaphragmatic (peri-
renal and perihepatic). Thereafter, maximum standardized up-
take values (SUVmax) were determined by the vendor-provided
software (Volumetrix for PET-CT; GE Healthcare) on PET
scans. Region of interest diameter was set at 1 cm; SUVmax was
body weight-corrected. For each patient showing 18F-FDG BAT
uptake, the maximum SUVmax was recorded. SUVmax normal-
ized to body weight is given by the following equation:
SUVmax  (ACvoi (kBq/mL))/(FDGdose (MBq)/BW (kg))
BAT activity was evaluated by recording the number of typical
anatomical areas of BAT showing FDG uptake, and SUVmax for
each area. The sum of SUVmax measurements was used for statis-
tical analysis (12, 13).
RMR was measured by indirect calorimetry using a canopy sys-
tem(Vmax29,SensorMedics,Anaheim,California) at a roomtem-
perature of 23° to 25°C and according to standard procedures (see
Ref. Marra). NEAT was evaluated according to Kousta et al (14) as
the SD from the average of 30 energy expenditure measurements in
the resting condition (ie, every minute for 30 min) based on the
assumptionthat, in thesteadystate, increasedfidgetingwill increase
resting energy expenditure (REE) variability. After RMR measure-
ments, single-frequency bioimpedentiometry (BIA) was also per-
formedat50KHz(STA/BIA;Akern,Firenze, Italy).Thedetermined
BIA variables were resistance and reactance: the resistance index
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was calculated as the ratio height2/Rx and the result used to obtain
fat-free mass (FFM) was calculated according to Kushner and
Schoeller (15).
Informed consent was obtained from all patients and volun-
teers before participation.
The protocol of the study was approved by Ethics Committee
of the Federico II University Hospital, Naples, Italy.
Statistics
Results are expressedasmeanandSD.Two-waystatistical anal-
ysis (SPSS-WIN version 10; SPSS, Chicago, Illinois) was performed
when appropriate to compare data between different groups (post
hoc analysis Tukey honestly significant difference). Wilcoxon rank
sum test has been performed for nonparametric data. Significant
differences between groups were confirmed with Mann-Whitney
test and two-sample Kolmogorov-Smirnov test. Simple linear cor-
relation was used to assess the associations between variables. Dif-
ferences were considered statistically significant when P  .05.
Results
The 4 groups of young women studied (CL, AN, R-AN,
and controls) did not differ in age or height; AN and CL
had body weight and BMI significantly lower than did
NW subjects; BMI and body weight values in R-AN pa-
tients were intermediate between those of AN and NW
participants. In Table 1, CL, AN, R-AN and, as reference,
NW values of our internal control group (1), BIA, and
measured RMR parameters are reported. The 3 groups
examined did not differ significantly for the FFM calcu-
lated; the phase angle was significantly higher (P  .05) in
CL than in AN and R-AN. REE was higher in CL than in
AN and R-AN patients and, when expressed per kilogram
FFM, it was significantly higher (P  .05) in CL than in AN
and R-AN. RQ did not differ between CL and AN pa-
tients. Fidgeting, corrected for REE, was significantly
higher (P  .05) in CL than in the other two groups.
As for 18F-FDG PET/CT, all CL subjects showed FDG
uptake in the regions investigated, with the following fre-
quency: neck and supraclavicular area in 7 subjects (100%),
thoracic and paravertebral in 6 (86%), mediastinal in 5
(71%), prevertebral and intercostal in 3 (43%), and parac-
ardiac and sovrarenal in two (28%). Alternatively, FDG up-
take could be described as present in 6 subjects in all the sites
investigated and in 1 patient in 2 of the 5 sites investigated.
None of the AN subjects, even after refeeding, showed evi-
denceofFDGuptake in thearea investigated.Moreoveronly
3 (12%) of the 24 NW females showed some FDG uptake,
limited to the neck and supraclavicular regions. In the 7 CL
and 3 NW subjects in whom BAT activity was detected, the
highest SUVmax values were observed in the supraclavicular
region; mean data and ranges are reported in Table 2.
In CL subjects, RMR, corrected RMR/FFM, RQ, and
fidgeting could be correlated to the sum of SUVmax values
recorded in the active anatomical sites presenting BAT. In
CL subjects, the sum of SUVmax had a positive linear
correlation with RMR (r  0.71, P  .07), RMR/FFM
Table 2. SUVmax and Mean SUVmax in CL and NW
CL (n  7) NW (n  3/24)
Mean SD Min-Max Mean SD Min-Max
SUVmax, g/mL 48.6a 33.4 3.2–93.2 2.9 8.7 0–38.2
mean SUVmax, g/mL 5.4a 3.7 0.36–10.36 0.32 0.96 0–4.24
AN data not reported (SUV always absent).
a
P  .05 vs NW.
Table 1. Body Composition, RMR, Fidgeting, and RQ
CL (n  7) AN (n  7) R-AN (n  3) NWa (n  20)
Weight, kg 41.1  4.7 39.6  3.9 46.2  2.4 56.0  6.2
BMI, kg/m2 16.2  0.9 15.3  0.8 18.8  1.1 21.7  2.4
FFM, kg 36.2  4.1 35.5  3.5 38.8  2.5 39.6  3.9
FAT, % 11.9  1.51 10.2  1.79 15.6  0.69a 28.9  6.5
Phase angle, degree 6.75  1.04b 5.39  0.40 5.76  0.86 6.24  1.12
RMR, kcal/die 1267  221c 1012  125 1078  72 1192  173
RMR/FFM, kcal/kg 35.9  9.6c 28.7  4.0 27.9  3.5 30.2  4.3
Fidgeting/RMR, % 2.5  0.2c 1.8  0.3 1.9  0.1 2.10  0.70
RQ 0.89  0.06 0.92  0.08 0.85  0.15 0.84  0.05
Abbreviation: FAT,     .
a Data of our laboratory reference group (1).
b
P  .05 R-AN vs CL and AN.
c
P  .05 CL vs R-AN and AN.
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(0.81, P  .03) (Figure 1) and a negative correlation with
fasting RQ (r  0.74, P  .05) (Figure 2).
Discussion
Basic research on the physiological role of BAT started in
the late 1950s and developed in the 1970s (16–20). BAT
was first described in newborns, whereas in adults, except
for some clinical observations in patients with end-stage
pheochromocytoma, BAT was considered absent or with-
out a significant physiological role (21). A possible role in
the pathogenesis of human obesity was considered ques-
tionable (22, 23). In recent years, with the advent of the
18F-FDG PET-CT technique, which was developed pri-
marily to identify secondary neoplasms, clear evidence of
BAT activity in adult humans emerged (3, 24–27), leading
to identification of some roles for BAT malfunctioning in
the development of currently common diseases (8, 28). In
the current study we confirm that REE is higher in CL than
in AN, even after refeeding of those with AN; this finding
is associated with a higher phase angle in CL, which is an
index of improved intracellular or extracellular water dis-
tribution and consequently of better FFM anatomy (1).
We also provide evidence, for the first time to the best of
our knowledge, that BAT activity is well represented in
resting, thermoneutral conditions in healthy young adult
females with CL and is correlated with the RMR, in par-
ticular when corrected for FFM. Thus, the results of our
study suggest that having active BAT contributes to con-
stitutional leanness. BAT activity is also inversely corre-
lated with RQ. These observations support the hypothesis
that BAT has a protective role toward fat mass accumu-
lation, mostly because of the preferential use of lipids as
substrate in resting, thermoneutral conditions, corre-
sponding to our experimental observation conditions.
This finding appears to be of some speculative interest if
we consider that in some groups of adult premenopausal
women, fat gain over time may be predicted by high RQ,
index of reduced fat oxidation as preferential fuel (29–
31). On the other hand, there seems to be no BAT activity
in AN, a marasma-like type of protein energy malnutrition
typically characterized by an adaptive reduction of RMR
to compensate chronic fuel deficiency caused by chronic
restrictive eating behavior. Thus, our results confirm pre-
vious observations that anorectic women have no detect-
able BAT (32). Furthermore, BAT activity could not be
detected even in the 3 R-AN patients studied in stable
refeeding conditions. In experimental models, BAT activ-
ity contributes to both cold- and diet-induced thermogen-
esis; we hypothesize that in our AN patients, refeeding
cannot be considered a real overfeeding stimulus able to
activate thermogenic mechanisms (33, 34). As to the sam-
ple representative of NW individuals, the group was re-
cruited among age-matched healthy women attending the
PET-CT radiology unit in the same period of the year.
Only 3 (12%) of the 24 subjects presented some BAT ac-
tivity, detectable in a small number of anatomical areas,
and the SUVmax was consistently lower than that seen in
CL. This finding suggests that in a thermoneutral envi-
ronment, NW subjects have limited BAT activity, whereas
CL females present persistent enhanced BAT activity.
These preliminary observations require additional inves-
tigations in larger groups of subjects of both sexes.
In conclusion, this study for the first time provides evi-
dence of active BAT in adult females with CL. Studies on
brown fat usually are carried out in cold conditions to en-
hance BAT activity (32). In the current protocol, we per-
formedexperimental thermoneutrality,whichmayrepresent
a limitation of the study, as may the lack of evaluation of
plasma and urine catecholamine, as has been performed re-
cently by other authors (35). Another limitation of this study
is thesmallsimplesize,whichlimits the interpretationofBAT
activity and its correlation with measurable parameters.
In this small, selected group of CL females BAT activity
was positively correlated with RMR corrected for FFM and
inversely correlated with RQ. These findings are suggestive
of a protective role of BAT, at least in CL, toward white fat
Figure 1. Linear correlation between composite SUVmax and RMR/
FFM in 7 constitutionally lean young women.
Figure 2. Linear correlation between composite SUV max and
respiratory quotient in 7 constitutionally lean young women.
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deposition, possibly through a preferential free fatty acid uti-
lization. Efforts to stimulate brown fat activity either phys-
iologically or pharmacologically to prevent excess white fat
accumulation are encouraged by this observation.
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